Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection

Table 1 Relationship between lymphocyte-to-monocyte ratio and clinicopathological characteristics

Variable	No. of patients	LMR		P value
		≤ 3.23 (n = 66)	> 3.23 (n = 144)
Age (yr)
< 60	165	52	113	0.959
≥ 60	45	14	31
Gender
Female	25	6	19	0.394
Male	185	60	125
Liver cirrhosis
Absent	49	7	42	0.003
Present	161	59	102
ALT (U/L)
≤ 75	172	51	121	0.238
> 75	38	15	23
Total bilirubin (μmol/L)
≤ 34	197	57	140	0.002
> 34	13	9	4
Albumin (g/L)
< 35	15	7	8	0.303
≥ 35	195	59	136
ALP (U/L)
≤ 100	171	51	120	0.294
> 100	39	15	24
AFP (ng/dL)
≤ 400	124	38	86	0.769
> 400	86	28	58
Tumor size (cm)
≤ 5	157	43	114	0.030
> 5	53	23	30
Tumor number
Single	184	59	125	0.597
Multiple	26	7	19
Portal vein thrombus
Absent	196	61	135	0.952
Present	14	5	9
Microvascular invasion
Absent	170	55	115	0.552
Present	40	11	29
Histological differentiation
Poor	22	8	14	0.598
Well and Moderate	188	58	130
ALC (× 109/L)
≤ 1.66	117	50	67	< 0.001
> 1.66	93	16	77
AMC (× 109/L)
≤ 0.29	57	3	54	< 0.001
> 0.29	153	63	90

AFP: Alpha-fetoprotein; ALT: Alanine aminotransferase; ALC: Absolute lymphocyte count; ALP: Alkaline phosphatase; AMC: Absolute monocyte count; LMR: Lymphocyte-to-monocyte ratio.